Cas no 14371-87-0 (3-propylpyrrolidine-2-carboxylic acid)
3-propylpyrrolidine-2-carboxylic acid Chemical and Physical Properties
Names and Identifiers
-
- Proline, 3-propyl-
- (2S)-3-propylpyrrolidine-2-carboxylic acid
- Proline, 3-propyl- (8CI,9CI)
- 3-propylpyrrolidine-2-carboxylic acid
- 3-Propyl-L-proline
- 3-n-propylproline
- SCHEMBL7676251
- 14371-87-0
- DTXSID80610888
-
- MDL: MFCD20647333
- Inchi: 1S/C8H15NO2/c1-2-3-6-4-5-9-7(6)8(10)11/h6-7,9H,2-5H2,1H3,(H,10,11)/t6?,7-/m0/s1
- InChI Key: JYQLFFLYIKPHHN-MLWJPKLSSA-N
- SMILES: OC([C@@H]1C(CCC)CCN1)=O
Computed Properties
- Exact Mass: 157.11035
- Monoisotopic Mass: 157.110278721g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
- Complexity: 147
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -1
- Topological Polar Surface Area: 49.3?2
Experimental Properties
- PSA: 49.33
3-propylpyrrolidine-2-carboxylic acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-225427-1g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 1g |
$1057.0 | 2023-09-15 | ||
| Enamine | EN300-225427-5g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 5g |
$3065.0 | 2023-09-15 | ||
| Enamine | EN300-225427-10g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 10g |
$4545.0 | 2023-09-15 | ||
| Enamine | EN300-225427-0.05g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 0.05g |
$888.0 | 2024-06-20 | |
| Enamine | EN300-225427-0.1g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 0.1g |
$930.0 | 2024-06-20 | |
| Enamine | EN300-225427-0.25g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 0.25g |
$972.0 | 2024-06-20 | |
| Enamine | EN300-225427-0.5g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 0.5g |
$1014.0 | 2024-06-20 | |
| Enamine | EN300-225427-1.0g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 1.0g |
$1057.0 | 2024-06-20 | |
| Enamine | EN300-225427-2.5g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 2.5g |
$2071.0 | 2024-06-20 | |
| Enamine | EN300-225427-5.0g |
3-propylpyrrolidine-2-carboxylic acid |
14371-87-0 | 95% | 5.0g |
$3065.0 | 2024-06-20 |
3-propylpyrrolidine-2-carboxylic acid Related Literature
-
1. 2-Amino ketene S,S-acetals as α-amino acid homoenolate equivalents. Synthesis of 3-substituted prolines and molecular structure of 2-(N-pivaloylpyrrolidin-2-ylidene)-1,3-dithianeWilliam O. Moss,Annette C. Jones,Richard Wisedale,Mary F. Mahon,Kieran C. Molloy,Robert H. Bradbury,Neil J. Hales,Timothy Gallagher J. Chem. Soc. Perkin Trans. 1 1992 2615
Additional information on 3-propylpyrrolidine-2-carboxylic acid
Introduction to 3-propylpyrrolidine-2-carboxylic acid (CAS No. 14371-87-0)
3-propylpyrrolidine-2-carboxylic acid, identified by the chemical compound code CAS No. 14371-87-0, is a significant intermediate in the realm of organic synthesis and pharmaceutical chemistry. This compound, featuring a pyrrolidine core substituted with a propyl group and a carboxylic acid functional group, has garnered attention due to its versatile applications in the development of bioactive molecules. The structural motif of 3-propylpyrrolidine-2-carboxylic acid makes it a valuable scaffold for designing novel therapeutic agents, particularly in the context of drug discovery and medicinal chemistry.
The molecular structure of 3-propylpyrrolidine-2-carboxylic acid consists of a six-membered heterocyclic ring containing one nitrogen atom, which is flanked by a propyl chain at the 3-position and a carboxylic acid group at the 2-position. This configuration imparts unique physicochemical properties, including solubility characteristics and reactivity patterns, that are exploited in synthetic protocols. The presence of both an amine-like nitrogen and a carboxylic acid moiety allows for diverse functionalization strategies, making it a cornerstone in the synthesis of more complex molecules.
In recent years, 3-propylpyrrolidine-2-carboxylic acid has been extensively studied for its potential applications in the pharmaceutical industry. Its structural framework is reminiscent of several biologically active compounds, suggesting that derivatives of this molecule could exhibit pharmacological properties relevant to various therapeutic areas. For instance, modifications at the propyl chain or the pyrrolidine ring have been explored to modulate binding affinity and selectivity towards target proteins or enzymes.
One of the most compelling aspects of 3-propylpyrrolidine-2-carboxylic acid is its role as a precursor in the synthesis of peptidomimetics. Peptidomimetics are designed to mimic the bioactivity of natural peptides while overcoming limitations such as poor bioavailability or susceptibility to enzymatic degradation. The pyrrolidine ring in 3-propylpyrrolidine-2-carboxylic acid can serve as a mimic for peptide bonds, allowing chemists to create analogs with enhanced stability and improved pharmacokinetic profiles. This has led to its incorporation into numerous research efforts aimed at developing novel treatments for diseases such as cancer, inflammation, and infectious disorders.
Recent advancements in computational chemistry have further highlighted the significance of 3-propylpyrrolidine-2-carboxylic acid. High-throughput virtual screening (HTVS) and molecular docking studies have been employed to identify potential drug candidates derived from this scaffold. These computational approaches leverage the known structural features of 3-propylpyrrolidine-2-carboxylic acid to predict interactions with biological targets, thereby accelerating the drug discovery process. Such methodologies have demonstrated promising results in identifying lead compounds with therapeutic potential.
The synthetic accessibility of 3-propylpyrrolidine-2-carboxylic acid also contributes to its appeal in medicinal chemistry. Several synthetic routes have been reported, ranging from multi-step organic transformations to more streamlined one-pot procedures. These methods often utilize readily available starting materials, making it feasible to produce quantities sufficient for both research and development purposes. The ability to efficiently synthesize this compound has enabled researchers to explore its derivatives more thoroughly, leading to a growing body of literature on its applications.
In conclusion, 3-propylpyrrolidine-2-carboxylic acid (CAS No. 14371-87-0) represents a versatile and valuable building block in pharmaceutical chemistry. Its unique structural features and functional groups make it an attractive scaffold for designing novel bioactive molecules. The ongoing research into peptidomimetics, computational drug discovery, and synthetic methodologies continues to underscore its importance in advancing therapeutic development. As our understanding of its potential expands, so too does the likelihood that derivatives of this compound will play pivotal roles in future medical treatments.
14371-87-0 (3-propylpyrrolidine-2-carboxylic acid) Related Products
- 3060-46-6((2S)-4-methyl-2-(methylamino)pentanoic acid)
- 42856-71-3((S)-2-Methylpyrrolidine-2-carboxylic acid)
- 80828-13-3((2R,3aR,7aR)-rel-OctahydroIndole-2-carboxylic Acid)
- 72000-65-8(2,5-Pyrrolidinedicarboxylicacid)
- 103201-78-1((2S,4S)-4-cyclohexylpyrrolidine-2-carboxylic acid)
- 9002-01-1(Streptokinase)
- 609-36-9(pyrrolidine-2-carboxylic acid)
- 147-85-3(L-Proline)
- 344-25-2(D-Proline)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)